Eric Dobmeier
2020
In 2020, Eric Dobmeier earned a total compensation of $6.2M as President and Chief Executive Officer at Aduro BioTech.
Compensation breakdown
| Non-Equity Incentive Plan | $256,113 |
|---|---|
| Option Awards | $4,181,817 |
| Salary | $437,802 |
| Stock Awards | $1,364,586 |
| Other | $2,000 |
| Total | $6,242,318 |
Dobmeier received $4.2M in option awards, accounting for 67% of the total pay in 2020.
Dobmeier also received $256.1K in non-equity incentive plan, $437.8K in salary, $1.4M in stock awards and $2K in other compensation.
Rankings
In 2020, Eric Dobmeier's compensation ranked 1,651st out of 13,090 executives tracked by ExecPay. In other words, Dobmeier earned more than 87.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,651 out of 13,090 | 87th |
Division Manufacturing | 623 out of 5,621 | 89th |
Major group Chemicals And Allied Products | 224 out of 2,254 | 90th |
Industry group Drugs | 187 out of 1,954 | 90th |
Industry Pharmaceutical Preparations | 130 out of 1,459 | 91st |
Source: SEC filing on April 23, 2021.
Dobmeier's colleagues
We found four more compensation records of executives who worked with Eric Dobmeier at Aduro BioTech in 2020.